Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Gene Therapy|October 1, 1996
In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16T Oligino, P L Poliani, P Marconi, et al.Neurological Research|July 1, 2006
Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing miceS Pellegatta, P L Poliani, D Corno, et al.Gene Therapy|February 7, 2003
Dexamethasone inhibits the anti-tumor effect of interleukin 4 on rat experimental gliomasS Benedetti, B Pirola, P L Poliani, et al.Journal of Neuroimmunology|September 2, 2000
Cytokines and immunity in multiple sclerosis: the dual signal hypothesisG Martino, R Furlan, E Brambilla, et al.Journal of Neurovirology|May 1, 1997
Herpes simplex virus vectors for gene transfer to the nervous systemW F Goins, D Krisky, P Marconi, et al.Gene Therapy|June 13, 2001
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H miceR Furlan, P L Poliani, P C Marconi, et al.European Journal of Immunology|February 12, 2000
Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3)F Mattner, S Smiroldo, F Galbiati, et al.Neuropathology and Applied Neurobiology|October 16, 2010
Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cellsF Orzan, S Pellegatta, P L Poliani, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 24, 1999
Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary studyR Furlan, M Filippi, A Bergami, et al.Gene Therapy|August 18, 2001
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 miceF Ruffini, R Furlan, P L Poliani, et al.Pageof 3